FDA Inspection
Biocon LimitedBiocon Limited – FDA Inspection, Mar 16, 2018
Record Details
This FDA Inspection record concerns Biocon Limited, with an inspection on March 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 63ab711a-8697-40d1-8346-076992fef96e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1044697
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Biocon Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | Not classified | Office of Inspections and Investigations | |
| February 26, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 5, 2019 | Not classified | Office of Inspections and Investigations | |
| September 21, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 3, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Biocon Limited
- FDA Inspection 1250808 - 2024-09-20
- FDA Inspection 1120320 - 2020-02-26
- FDA Inspection 1084007 - 2019-03-05
- FDA Inspection 1070344 - 2018-09-21
- FDA Inspection 1011618 - 2017-04-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.